An IL-6/STAT3/MR/FGF21 axis mediates heart-liver cross-talk after myocardial infarction
Science Advances · 07.04.2023 · 9 (14)
DOI: 10.1126/sciadv.ade4110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.04.2023. Verfasst von Jian-Yong Sun und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School o…. Hauptthemen laut MEDLINE: Interleukin-6, Myocardial Infarction. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The liver plays a protective role in myocardial infarction (MI). However, very little is known about the mechanisms. Here, we identify mineralocorticoid receptor (MR) as a pivotal nexus that conveys communications between the liver and the heart during MI. Hepatocyte MR deficiency and MR antagonist spironolactone both improve cardiac repair after MI through regulation on hepatic fibroblast growth factor 21 (FGF21), illustrating an MR/FGF21 axis that underlies the liver-to-heart protection against MI. In addition, an upstreaming acute interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) pathway transmits the heart-to-liver signal to suppress MR expression after MI. Hepatocyte Il6 receptor deficiency and Stat3 deficiency both aggravate cardiac injury through their regulation on the MR/FGF21 axis. Therefore, we have unveiled an IL-6/STAT3/MR/FGF21 signaling axis that mediates heart-liver cross-talk during MI. Targeting the signaling axis and the cross-talk could provide new strategies to treat MI and heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China.
- National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai 200011, China.
- Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
- Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Jiangsu Key Laboratory of Molecular Medicine, Chemistry and Biomedicine Innovation Center (ChemBIC), Model A…
ORCID-Profile: Jian-Yong Sun, Lin-Juan Du, Xue-Rui Shi, Yu-Yao Zhang, Yong-Li Wang, Bo-Yan Chen, Hong Zhu, Cheng-Chao Ruan, Zhenji Gan, Zhinan Yin, Xiaoxiang Yan, Ruo-Gu Li, Sheng-Zhong Duan
Zitieren
APA
Sun, J. Y., Du, L. J., Shi, X. R., Zhang, Y. Y., Liu, Y., Wang, Y. L., Chen, B. Y., Liu, T., Zhu, H., Liu, Y., Ruan, C. C., Gan, Z., Ying, H., Yin, Z., Gao, P. J., Yan, X., Li, R. G., & Duan, S. Z. (2023). An IL-6/STAT3/MR/FGF21 axis mediates heart-liver cross-talk after myocardial infarction. Science Advances, 9(14). https://doi.org/10.1126/sciadv.ade4110
Vancouver
Sun JY, Du LJ, Shi XR, Zhang YY, Liu Y, Wang YL, et al. An IL-6/STAT3/MR/FGF21 axis mediates heart-liver cross-talk after myocardial infarction. Science Advances. 2023;9(14). doi:10.1126/sciadv.ade4110
BibTeX
@article{Sun2023,
author = {Sun, Jian-Yong and Du, Lin-Juan and Shi, Xue-Rui and Zhang, Yu-Yao and Liu, Yuan and Wang, Yong-Li and Chen, Bo-Yan and Liu, Ting and Zhu, Hong and Liu, Yan and Ruan, Cheng-Chao and Gan, Zhenji and Ying, Hao and Yin, Zhinan and Gao, Ping-Jin and Yan, Xiaoxiang and Li, Ruo-Gu and Duan, Sheng-Zhong},
title = {An IL-6/STAT3/MR/FGF21 axis mediates heart-liver cross-talk after myocardial infarction},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {14},
doi = {10.1126/sciadv.ade4110}
}
EUVIMED